International Clinical Trial: Retrospective Analysis of the Second Year of Safety Surveillance of the Qdenga(R) (TAK-003) Vaccine in Private Vaccination Centers, Including a Sub-analysis of Safety in Adults Over 60 Years of Age

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07812142) titled 'Retrospective Analysis of the Second Year of Safety Surveillance of the Qdenga(R) (TAK-003) Vaccine in Private Vaccination Centers, Including a Sub-analysis of Safety in Adults Over 60 Years of Age' on Sept. 4.

Study Type: Observational

Primary Sponsor: Fundación Vacunar

Condition: Dengue Vaccines

Intervention: Biological: Tak-003

Recruitment Status: Not recruiting

Date of First Enrollment: November 2, 2024

Target Sample Size: 94526

Countries of Recruitment: Argentina

To know more, visit https://clinicaltrials.gov/study/NCT07812142

Published by HT Digital Content Services with permission from Healt...